- Home
- PMVP vs BRNS Comparison
PMVP vs BRNS Comparison
Compare PMVP & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PMVP | BRNS |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.8M | 55.9M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PMVP | BRNS |
|---|---|---|
| Price | $1.62 | $0.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $5.00 | $4.00 |
| AVG Volume (30 Days) | ★ 815.6K | 67.7K |
| Earning Date | 06-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.85 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $14,969,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1766.46 |
| 52 Week Low | $0.82 | $0.56 |
| 52 Week High | $1.88 | $2.91 |
Technical Indicators
Market Signals| Indicator | PMVP | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 66.26 | 36.40 |
| Support Level | $1.32 | $0.56 |
| Resistance Level | $1.86 | $0.76 |
| Average True Range (ATR) | 0.14 | 0.07 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 71.51 | 1.43 |
Price Performance
Historical ComparisonAbout PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.